These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Cerebrospinal fluid biochemical markers in central nervous system tumors: a review. Wasserstrom WR, Schwartz MK, Fleisher M, Posner JB. Ann Clin Lab Sci; 1981; 11(3):239-51. PubMed ID: 6166240 [No Abstract] [Full Text] [Related]
5. Sensitivity and specificity of single and combined tumour markers in the diagnosis of leptomeningeal metastasis from breast cancer. Twijnstra A, van Zanten AP, Nooyen WJ, Ongerboer de Visser BW. J Neurol Neurosurg Psychiatry; 1986 Nov; 49(11):1246-50. PubMed ID: 3540216 [Abstract] [Full Text] [Related]
6. Sensitivity and specificity of cerebrospinal fluid biochemical markers of central nervous system metastases. Ongerboer de Visser BW, van Zanten AP, Twijnstra A, Nooyen WJ, Hart AA. Prog Exp Tumor Res; 1985 Nov; 29():105-15. PubMed ID: 3906759 [No Abstract] [Full Text] [Related]
7. [Cerebrospinal fluid changes in sarcomatosis of the pia mater of the brain and spinal cord]. Neretin VIa, Antonova TS, Kir'iakov VA. Sov Med; 1981 Nov; (12):72-4. PubMed ID: 7336266 [No Abstract] [Full Text] [Related]
8. [A correlative study of cytology and carcinoembryonic antigen determination in cerebrospinal fluid in the diagnosis of breast cancer cerebro-meningeal metastases (author's transl)]. Fontaniere B, Ardiet C, Clavel M, Lahneche B, Clavel E, Faucon M. Arch Anat Cytol Pathol; 1981 Nov; 29(5):287-90. PubMed ID: 7305463 [No Abstract] [Full Text] [Related]
9. Cerebrospinal fluid beta-glucuronidase activities in patients with central nervous system metastases. van Zanten AP, Twijnstra A, van Benthem V, Hart AA, Ongerboer de Visser BW. Clin Chim Acta; 1985 Apr 15; 147(2):127-34. PubMed ID: 3987058 [Abstract] [Full Text] [Related]
10. Measurements of CSF biochemical tumor markers in patients with meningeal carcinomatosis and brain tumors. Nakagawa H, Kubo S, Murasawa A, Nakajima S, Nakajima Y, Izumoto S, Hayakawa T. J Neurooncol; 1992 Feb 15; 12(2):111-20. PubMed ID: 1560255 [Abstract] [Full Text] [Related]
11. Lactic dehydrogenase isoenzymes in the cerebrospinal fluid of patients with systemic cancer. Fleisher M, Wasserstrom WR, Schold SC, Schwartz MK, Posner JB. Cancer; 1981 Jun 01; 47(11):2654-9. PubMed ID: 7260857 [Abstract] [Full Text] [Related]
12. Diagnosis and treatment of leptomeningeal metastases from solid tumors: experience with 90 patients. Wasserstrom WR, Glass JP, Posner JB. Cancer; 1982 Feb 15; 49(4):759-72. PubMed ID: 6895713 [Abstract] [Full Text] [Related]
14. [Brain metastasis and the carcinoembryonic antigen]. Noris-García E, Escobar-Pérez X. Rev Neurol; 1982 Feb 15; 38(3):267-70. PubMed ID: 14963857 [Abstract] [Full Text] [Related]
15. [A diffuse metastatic leptomeningeal carcinomatosis from gallbladder cancer; case report]. Takeuchi T, Ogawa H, Kasahara E, Sakurada M, Satoh S. No Shinkei Geka; 1991 Nov 15; 19(11):1091-5. PubMed ID: 1762661 [Abstract] [Full Text] [Related]
16. Neurologic complications of prostate cancer. Benjamin R. Am Fam Physician; 2002 May 01; 65(9):1834-40. PubMed ID: 12018806 [Abstract] [Full Text] [Related]
17. The clinical relevance of locally produced carcinoembryonic antigen in cerebrospinal fluid. Jacobi C, Reiber H, Felgenhauer K. J Neurol; 1986 Nov 01; 233(6):358-61. PubMed ID: 3806144 [Abstract] [Full Text] [Related]